iosBio Logo (CMYK).png
iosBio signs exclusive worldwide licensing agreement granting ImmunityBio rights to OraPro™ oral vaccine platform technology for COVID-19  
January 12, 2021 07:00 ET | iosBio
PRESS RELEASE iosBio signs exclusive worldwide licensing agreement granting ImmunityBio rights to OraPro™ oral vaccine platform technology for COVID-19             iosBio licenses its OraProTM...
iosBio Logo (CMYK).png
iosBio signs exclusive worldwide licensing agreement granting ImmunityBio rights to OraPro™ oral vaccine platform technology for COVID-19  
January 12, 2021 02:00 ET | iosBio
PRESS RELEASE iosBio signs exclusive worldwide licensing agreement granting ImmunityBio rights to OraPro™ oral vaccine platform technology for COVID-19             iosBio licenses its OraProTM...
15-SORRENTO-Therapeutics-Logo-FINAL.png
Los Angeles Court Rejects Patrick Soon-Shiong’s Attempt to Avoid Sorrento Litigation Allowing Arbitration Case to Move Forward
October 15, 2019 22:36 ET | Sorrento Therapeutics, Inc.
SAN DIEGO, Oct. 15, 2019 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento") announced today that a Los Angeles Superior Court judge has rejected Patrick Soon-Shiong’s attempt...